Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-027861
Filing Date
2024-11-27
Accepted
2024-11-27 16:39:29
Documents
1
Period of Report
2024-11-26

Document Format Files

Seq Description Document Type Size
1 form4-11272024_091125.html 4  
1 form4-11272024_091125.xml 4 12885
  Complete submission text file 0001415889-24-027861.txt   15698
Mailing Address 565 EVERETT AVENUE PALO ALTO CA 94301
Business Address
AKKARAJU SRINIVAS (Reporting) CIK: 0001253170 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36327 | Film No.: 241511839

Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Issuer) CIK: 0001404644 (see all company filings)

EIN.: 980542593 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301
Business Address 628 MIDDLEFIELD ROAD PALO ALTO CA 94301 (650) 285-4270
Samsara BioCapital, L.P. (Reporting) CIK: 0001699737 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36327 | Film No.: 241511840

Mailing Address 251 CHURCHILL AVENUE PALO ALTO CA 94301
Business Address 251 CHURCHILL AVENUE PALO ALTO CA 94301 (650) 843-5000
Samsara BioCapital GP, LLC (Reporting) CIK: 0001888829 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36327 | Film No.: 241511841